Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Oct 26, 2020; 8(20): 4807-4815
Published online Oct 26, 2020. doi: 10.12998/wjcc.v8.i20.4807
Table 1 Demographics and clinical characteristics of patients
Total (n = 304)Improved (n = 135)Not-improved (n = 169)P value
Demographics
Male, n (%)257 (84.5)111 (82.2)146 (86.4)0.318
Age, yr (mean ± SD)49.81 ± 13.0350.47 ± 12.7849.28 ± 13.240.67
Co-morbidity, n (%)92 (32.2)38 (28.8)53 (31.4)0.455
ASCI characteristics
Etiology, n (%)0.456
Motor vehicle crashes90 (29.6)41 (30.4)49 (29.0)
High-altitude fall injuries37 (12.2)13 (9.6)24 (14.2)
Unintentional falls136 (44.7)66 (48.9)70 (41.4)
Bruise by heavy object19 (6.3)6 (4.4)13 (7.7)
Other22 (7.2)9 (6.7)13 (7.7)
Multiple trauma, n (%)41 (13.5)13 (9.6)28 (16.6)0.078
Fracture, n (%)137 (45.1)52 (38.5)85 (50.3)0.040a
Region of fracture, n (%)0.042a
Cervical269 (88.5)126 (93.3)143 (84.6)
Lumbar24 (7.9)5 (84.6)19 (11.2)
Thoracic11 (3.6)4 (3.0)7 (4.1)
ASIA grade at admission0.0
A78 (25.7)14 (10.4)64 (37.9)
B33 (10.9)16 (11.9)17 (10.1)
C66 (21.7)47 (34.8)19 (11.2)
D127 (41.8)58 (43.0)69 (40.8)
Time from event to visit3.06 ± 2.132.7 ± 1.9632.9 ± 2.200.019a
Treatment (h)
Time from event to surgery0.005c
Within 72 h133 (43.8)71 (52.6)62 (36.7)
After 72 h171 (56.3)64 (47.4)107 (63.3)
Steroid usage208 (68.4)87 (64.4)169 (71.6)0.182
Complications100 (32.9)33 (24.4)67 (39.6)0.005c
Hospital stay (d)9.89 ± 10.117.79 ± 5.9211.55 ± 12.250.002c
ICU admission, n (%)95 (31.3)34 (25.2)61 (36.1)0.041a
Table 2 Steroid treatment
SteroidNon-steroidP value
Average hospitalization days10.32 ± 11.48.94 ± 6.40.117
Average hospitalization days in ICU10.75 ± 11.97.68 ± 6.30.095
Mean dose of steroids (mg/d)
Dexamethasone15.20 ± 5.0
Methylprednisolone286.02 ± 213.4
Total dose of steroids (mg)
Dexamethasone42.66 ± 23.5
Methylprednisolone833.96 ± 717.8
Table 3 Complications in the Steroid group and Non-Steroid group
SteroidNon-steroidP value
Pneumonia (n = 53)4670.002c
Electrolyte disturbances (n = 37)2980.164
DVT (n = 17)1160.734